Co-administration with A1M does not influence apoptotic response of (177)Lu-octreotate in GOT1 neuroendocrine tumors

Recombinant α(1)-microglobulin (A1M) is a proposed radioprotector during (177)Lu-octreotate therapy of neuroendocrine tumors (NETs). To ensure a maintained therapeutic effect, we previously demonstrated that A1M does not affect the (177)Lu-octreotate induced decrease in GOT1 tumor volume. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Rassol, Nishte, Andersson, Charlotte, Pettersson, Daniella, Al-Awar, Amin, Shubbar, Emman, Kovács, Anikó, Åkerström, Bo, Gram, Magnus, Helou, Khalil, Forssell-Aronsson, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115890/
https://www.ncbi.nlm.nih.gov/pubmed/37076494
http://dx.doi.org/10.1038/s41598-023-32091-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115890/
https://www.ncbi.nlm.nih.gov/pubmed/37076494
http://dx.doi.org/10.1038/s41598-023-32091-9

Ejemplares similares